Mason firm adds former Assurex Health executive to C-suite, hints at IPO

Genetesis, a Mason startup that’s developing medical devices to detect heart disease and is considering an initial public offering of stock, has hired a former Assurex Health executive as chief business officer.

Peter Donato was chief financial officer for Mason-based Assurex Health from 2015 to 2017, but the company has rebranded as Myriad Neuroscience since being bought by Myriad Genetics of Salt Lake City in a deal worth at least $225 million. Donato played a key role in the Assurex deal, which could be worth up to $410 million if milestones are hit.

Click here to read the complete article.

Story excerpt provided by Cincinnati Business Courier.

Written by Barrett J. Brunsman.

Originally published August 27, 2019.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: